Peter L. Anderson

1999–2025 年に発表

120
論文数
18,568
被引用数
60
h 指数
113
i10 指数

被引用数

Peter L. Anderson の年別被引用数1988 年: 被引用 5 件1995 年: 被引用 2 件2000 年: 被引用 3 件2001 年: 被引用 11 件2002 年: 被引用 20 件2003 年: 被引用 14 件2004 年: 被引用 14 件2005 年: 被引用 13 件2006 年: 被引用 12 件2007 年: 被引用 10 件2008 年: 被引用 23 件2009 年: 被引用 34 件2010 年: 被引用 21 件2011 年: 被引用 81 件2012 年: 被引用 101 件2013 年: 被引用 89 件2014 年: 被引用 122 件2015 年: 被引用 154 件2016 年: 被引用 187 件2017 年: 被引用 195 件2018 年: 被引用 209 件2019 年: 被引用 875 件2020 年: 被引用 757 件2021 年: 被引用 722 件2022 年: 被引用 625 件2023 年: 被引用 442 件2024 年: 被引用 704 件2025 年: 被引用 228 件2026 年: 被引用 1 件1989〜1994 年は被引用が無いため表示していません1996〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,100 件、この内訳の 39.2%イギリス: 引用元論文 363 件、この内訳の 6.8%南アフリカ: 引用元論文 354 件、この内訳の 6.6%カナダ: 引用元論文 185 件、この内訳の 3.5%ケニア: 引用元論文 170 件、この内訳の 3.2%ウガンダ: 引用元論文 136 件、この内訳の 2.5%中国: 引用元論文 132 件、この内訳の 2.5%ブラジル: 引用元論文 126 件、この内訳の 2.4%オランダ: 引用元論文 126 件、この内訳の 2.3%スイス: 引用元論文 124 件、この内訳の 2.3%フランス: 引用元論文 122 件、この内訳の 2.3%オーストラリア: 引用元論文 106 件、この内訳の 2%
0%39.2%その他 24.4%

分野

  • Medicine79.9%
  • Immunology and Microbiology7.8%
  • Biochemistry, Genetics and Molecular Biology2.5%
  • Psychology2.4%
  • Health Professions1.8%
  • Social Sciences1.8%
  • その他3.8%

トピック

  • HIV/AIDS Research and Interventions25.5%
  • HIV, Drug Use, Sexual Risk10.8%
  • HIV Research and Treatment8.4%
  • HIV/AIDS drug development and treatment8.1%
  • Sex work and related issues6.9%
  • Adolescent Sexual and Reproductive Health6.5%
  • その他33.8%

共著者

全論文

検索で開く
  1. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Estelle Piwowar‐Manning, Mark A. Marzinke, Craig W. Hendrix, Maoji Li, Zhe Wang, Jeanne Marrazzo, Eric S. Daar, Aida Asmelash, Todd T. Brown, Peter L. Anderson, Susan H. Eshleman, Marcus Bryan, Cheryl Blanchette, Jonathan Lucas, Christina Psaros, Steven A. Safren, Jeremy Sugarman, Hyman Scott, Joseph J. Eron, Sheldon D. Fields, Nirupama Sista, Kailazarid Gomez-Feliciano, Andrea Jennings, Ryan Kofron, Timothy H. Holtz, Katherine Shin, James F. Rooney, Kimberly Y. Smith, William Spreen, David M. Margolis, Alex R. Rinehart, Adeola Adeyeye, Myron S. Cohen, Marybeth McCauley, Beatriz Grinsztejn - New England Journal of Medicine 2021 被引用: 853

  2. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James F. Rooney, Howard S. Jaffe, Ana I. Martínez, David Burns, David V. Glidden - New England Journal of Medicine 2010 被引用: 5,133

  3. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nirupama Sista, Adeola Adeyeye, James F. Rooney, Alex R. Rinehart, William Spreen, Kimberly Y. Smith, Brett Hanscom, Myron S. Cohen, Mina C. Hosseinipour, Aida Asmelash, Alice Sehurutshi, Allan Baguma, Anita Marais, Barbarah Kawoozo, Bongiwe Prudence Malinga, Brenda Gati Mirembe, Brenda Okech, Bryan Esterhuizen, Caroline Murombedzi, Daphne Gadama, Eldinah Hwengwere, Elizabeth Roos, Elizabeth S Magada, Emily Shava, Estelle Piwowar-Manning, Eunice Tahuringana, Felix GS Muhlanga, Francesca Conradie, Frank Angira, Gertrude Nanyonjo, Girisha Kistnasami, Hazzie Mvula, Ishana Naidoo, Jaco Horak, Jane Jere, Jeeva Moodley, Katie Shin, Kerry Nel, Kevin Bokoch, Lilian Birungi, Lynda Emel, Maletsatsi Monametsi, Marvelous Sibanda, Mercy Mutambanengwe, Miria Chitukuta, Moleen Matimbira, Muchaneta Bhondai-Mhuri, Ncamsile Sibisi, Neetha Morar, Netsai Mudzonga, Paul Natureeba, Paul Richardson, Petina Musara, Pippa Macdonald, Rejoice Nkambule, Repelang Mosime, Rhonda White, Ribka Berhanu, Ritha Ncube-Sihlongonyane, Rogers Sekabira, Samantha Siva, Saresha Pillay, Shamelle Govender, Sheiala Bamweyana, Siyabonga Nzimande, Steve Innes, Sufia Dadabhai, Taraz Samandari, Tchangani Tembo, Thandie Lungu Mabedi ほか 9 名 - The Lancet 2022 被引用: 540

  4. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2014 被引用: 1,250

  5. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2020 被引用: 424

  6. Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

    著者: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2012 被引用: 1,043

  7. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2021 被引用: 178

  8. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services

    著者: , , , , , , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2015 被引用: 628

  9. Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study

    著者: , , , , , , , , , , , , - Clinical Infectious Diseases 2018 被引用: 163

  10. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the International AIDS Society 2022 被引用: 93

  11. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Craig W. Hendrix, Peter L. Anderson, Kenneth Ngure - The Lancet HIV 2023 被引用: 60

  12. Viral and host mediators of non-suppressible HIV-1 viremia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel R. Kuritzkes, Mathias Lichterfeld, Scott F. Sieg, Athe Tsibris, Mary Carrington, Zabrina L. Brumme, José Castillo‐Mancilla, Alan Engelman, Gaurav D. Gaiha, Jonathan Z. Li - Nature Medicine 2023 被引用: 48

  13. Defining success with HIV pre-exposure prophylaxis

    著者: , , , , , , , , , , , - AIDS 2015 被引用: 318

  14. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Cândida de Souza Dantas, Cristiane R. V. Castro, Karine Milani da Silva Dias, Camila Sunaitis Donini, Aline Tatiane Lumertz dos Anjos, Arlene Augusta dos Santos, Rita de Cássia Elias Estrela, Nilo Martinez Fernandes, Lilian Ferrari, Josias Freitas, Tatiane da Silva Gomes, Maura L Gonzalez, Raphaela Goulart, José Roberto Granjeiro, Marcus Lacerda, Priscilla de Lima e Menezes, Gustavo Mizuno, Laylla Monteiro, Issler Moraes, Carlos Otávio Fiúza Moreira, Denise Sales Mourão, Zelinda Bartolomei Nakagawa, Sandro Nazer, Maria Angelica Alcalá Neves, Roberta Schiavon Nogueira, Fatuma Odongo, Tiago Jordão Porto, Gladys Villas Boas do Prado, Marcia Puerro, Gisele N. Reis, Valéria Ribeiro, Charlene Rocha, Camila Rodrigues, Rafael S. Salles, Mariana M. Sauer, Taís Nóbrega de Sousa, Celso Oliveira Tavares, Claudia Satiko Tomiyama, Helena Tomiyama, Desirée Vieira, Vinícius Vieira, Larissa M. Villela, Daniel M. McMahon Waite, Nélio Zuccaro - The Lancet HIV 2018 被引用: 210

  15. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2023 被引用: 65

  16. Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

    著者: , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2017 被引用: 279

  17. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 被引用: 130

  18. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Violet Kwach, Alfred Obiero, Stella Njuguna, Millicent Faith Akinyi, Lilian Adipo, Sylvia Akinyi, Catherine Kiptiness, Nicholas Thuo, Stephen Gakuo Maina, Irene Njeru, Peter Mogere, Sarah Mbaire, Murugi Micheni, Lynda Oluoch, John Njoroge, Snaidah Ongachi, Jacinta Nyokabi, Lindsey Garrison, Maria Pyra, Katherine K. Thomas, Nicholas Musinguzi, Susie Valenzuela, Susan Morrison - The Lancet HIV 2021 被引用: 85

  19. Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions

    著者: , , , , , - Current HIV/AIDS Reports 2020 被引用: 144

  20. Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure

    著者: , , , , , , , , , , - AIDS Research and Human Retroviruses 2012 被引用: 331

  21. Updating the Adherence–Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women

    著者: , , - Clinical Infectious Diseases 2023 被引用: 36

  22. Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2023 被引用: 29

  23. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM

    著者: , , , , , , , , , , , , , , , , - JAIDS Journal of Acquired Immune Deficiency Syndromes 2016 被引用: 278

  24. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

    著者: , , , , , , , , , , , , , , , , , - JAMA Pediatrics 2017 被引用: 226